Almac Clinical Services has launched two clinical trial supply systems that it believes will help significantly in removing bottlenecks within the supply chain.
A new system of automated label verification was introduced following analysis of the current industry practice of 200% manual checking of both fixed and variable text on clinical trial study kit labels. Almac 's new system effectively removes the requirement for manual checking of study labels, greatly enhancing the speed of availability and providing a more robust audit trail.
The label verification system breaks new ground in that variable content, including randomisation details, is checked and verified by the system as well as industry standard fixed text checking.
Almac Clinical Services has also introduced a fully automated modular over-encapsulation system that provides a significant addition to the tools available for blinding of comparator products in clinical trials. This system removes the requirements for individual tooling for each tablet shape/size, resulting in improved timelines and hence start dates of the clinical trial.
'These projects are further evidence of our success in designing services that deliver industry-leading solutions into the marketplace,' said Robert Dunlop, president and md, Almac Clinical Services. 'We have identified bottlenecks that are common within the clinical supply chain and targeted our solutions to these two key areas. We are confident that our automated label verification system and new array of comparator blinding options will assist in ensuring trials are started on time and lead times are shortened to bring drugs to market.'
